Patrick Doherty was a healthy, active 65-year-old living County Donegal, Ireland when he was diagnosed with transthyretin amyloidosis, the same rare genetic disease that killed his father. When he visited a doctor, he learned of a new experimental treatment for the condition—with an emphasis on the "experimental" side. — Read the rest
